Stimulant use for self-management of pain among safety-net patients with chronic non-cancer pain.
Chronic pain
cocaine
methamphetamine
pain management
safety-net clinic
stimulants
Journal
Substance abuse
ISSN: 1547-0164
Titre abrégé: Subst Abus
Pays: United States
ID NLM: 8808537
Informations de publication
Date de publication:
2022
2022
Historique:
pubmed:
3
4
2021
medline:
15
4
2022
entrez:
2
4
2021
Statut:
ppublish
Résumé
Chronic pain affects one-fifth of US adults. Reductions in opioid prescribing have been associated with increased non-prescription opioid use and, chronologically, increased stimulant (methamphetamine and cocaine) use. While non-prescription opioid use is commonly attributed to pain self-management, the role of stimulants in managing pain is unclear. We analyzed baseline data from a longitudinal study of patients with chronic non-cancer pain in an urban safety-net healthcare system who had been prescribed an opioid for ≥3 of the last 12 months, and had a history of non-prescription opioid, cocaine, or amphetamine use ( Fifty-two percent of participants with past-year stimulant use reported using stimulants in the past year to treat pain. Participants who used stimulants for pain reported slightly higher average pain in the past 3 months (median of 8 (IQR: 6-8) vs 7 (7-9) out of 10, Stimulants may be used for pain self-management, particularly for neuropathic pain and among women. Our findings suggest an underexplored motivation for stimulant use in an era of reduced access to prescribed opioids.
Sections du résumé
BACKGROUND
BACKGROUND
Chronic pain affects one-fifth of US adults. Reductions in opioid prescribing have been associated with increased non-prescription opioid use and, chronologically, increased stimulant (methamphetamine and cocaine) use. While non-prescription opioid use is commonly attributed to pain self-management, the role of stimulants in managing pain is unclear.
METHODS
METHODS
We analyzed baseline data from a longitudinal study of patients with chronic non-cancer pain in an urban safety-net healthcare system who had been prescribed an opioid for ≥3 of the last 12 months, and had a history of non-prescription opioid, cocaine, or amphetamine use (
RESULTS
RESULTS
Fifty-two percent of participants with past-year stimulant use reported using stimulants in the past year to treat pain. Participants who used stimulants for pain reported slightly higher average pain in the past 3 months (median of 8 (IQR: 6-8) vs 7 (7-9) out of 10,
CONCLUSION
CONCLUSIONS
Stimulants may be used for pain self-management, particularly for neuropathic pain and among women. Our findings suggest an underexplored motivation for stimulant use in an era of reduced access to prescribed opioids.
Identifiants
pubmed: 33798030
doi: 10.1080/08897077.2021.1903654
pmc: PMC8791072
mid: NIHMS1770353
doi:
Substances chimiques
Analgesics, Opioid
0
Cocaine
I5Y540LHVR
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
179-186Subventions
Organisme : NIA NIH HHS
ID : K24 AG046372
Pays : United States
Organisme : NIDA NIH HHS
ID : K24 DA042720
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA040189
Pays : United States
Organisme : NIDA NIH HHS
ID : R25 DA028567
Pays : United States
Références
Peptides. 2018 Dec;110:56-77
pubmed: 30391426
Drug Alcohol Depend. 2017 Nov 1;180:376-384
pubmed: 28961544
Drug Alcohol Depend. 1986 May;17(1):1-13
pubmed: 3720527
Gend Med. 2008 Mar;5(1):24-35
pubmed: 18420163
Pain. 2005 Mar;114(1-2):29-36
pubmed: 15733628
JAMA. 2015 Aug 4;314(5):501-10
pubmed: 26241601
Psychol Med. 2020 Jun;50(8):1368-1380
pubmed: 31298180
Pain. 2008 Jul 31;137(3):681-688
pubmed: 18439759
Aust N Z J Psychiatry. 2020 Aug;54(8):808-817
pubmed: 32447969
Drug Alcohol Rev. 2014 May;33(3):287-95
pubmed: 24628655
Pain Manag. 2014 Jan;4(1):27-35
pubmed: 24641341
Neural Plast. 2017;2017:9724371
pubmed: 28706741
Brain Res. 1989 Feb 13;479(2):306-12
pubmed: 2647210
Subst Use Misuse. 2017 Jul 3;52(8):1051-1058
pubmed: 28323507
Pharmacoepidemiol Drug Saf. 2016 Jun;25(6):733-7
pubmed: 26693665
AIDS Behav. 2014 Jul;18(7):1359-67
pubmed: 24287786
Drug Alcohol Depend. 2013 Jul 1;131(1-2):23-35
pubmed: 23490450
Methods Mol Biol. 2010;617:165-8
pubmed: 20336421
Discov Med. 2018 Nov;26(144):197-206
pubmed: 30695679
Pain. 2008 Jun;136(3):380-387
pubmed: 17888574
Pain Pract. 2015 Jan;15(1):4-11
pubmed: 24134430
J Pain. 2006 Apr;7(4):281-9
pubmed: 16618472
Behav Pharmacol. 2009 Oct;20(7):623-30
pubmed: 19741505
J Assoc Nurses AIDS Care. 2006 Sep-Oct;17(5):7-14
pubmed: 16979510
Pain Med. 2015 Apr;16(4):706-14
pubmed: 25645646
PLoS One. 2020 May 4;15(5):e0232538
pubmed: 32365132
N Engl J Med. 1977 Mar 31;296(13):712-5
pubmed: 320478
Aust N Z J Psychiatry. 2016 Mar;50(3):203-7
pubmed: 26906078
Peptides. 2011 Feb;32(2):317-26
pubmed: 21167239
PLoS One. 2020 Mar 25;15(3):e0230408
pubmed: 32210442
J Clin Psychopharmacol. 2017 Aug;37(4):412-418
pubmed: 28590365
J Affect Disord. 2009 Apr;114(1-3):163-73
pubmed: 18752852
Diabet Med. 2012 May;29(5):578-85
pubmed: 22023377
Pain Rep. 2017 Apr 14;2(3):e593
pubmed: 29392209
MMWR Morb Mortal Wkly Rep. 2018 Sep 14;67(36):1001-1006
pubmed: 30212442
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941